(0.07%) 5 520.75 points
(0.11%) 39 886 points
(0.16%) 19 782 points
(0.01%) $81.64
(0.50%) $2.83
(-0.33%) $2 336.70
(-0.03%) $29.52
(0.30%) $1 004.80
(0.01%) $0.932
(0.02%) $10.54
(-0.01%) $0.788
(-0.57%) $87.50
1.36% $ 26.44
Live Chart Being Loaded With Signals
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions...
Stats | |
---|---|
Dzisiejszy wolumen | 586 176 |
Średni wolumen | 581 237 |
Kapitalizacja rynkowa | 998.76M |
EPS | $-1.010 ( Q1 | 2024-05-08 ) |
Następna data zysków | ( $-0.980 ) 2024-08-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-5.57 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.0670 (0.25%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-06-17 | Farrow Jeffrey S | Sell | 27 881 | Restricted Stock Units |
2024-06-17 | Farrow Jeffrey S | Buy | 27 881 | Common Stock |
2024-06-18 | Farrow Jeffrey S | Sell | 10 445 | Common Stock |
2024-06-13 | Goldberg Andrew D. | Buy | 5 000 | Stock Option (right to buy) |
2024-06-13 | Goldberg Andrew D. | Buy | 3 350 | Restricted Stock Units |
INSIDER POWER |
---|
41.86 |
Last 100 transactions |
Buy: 916 239 | Sell: 431 382 |
Wolumen Korelacja
Tarsus Pharmaceuticals, Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
SILK | 0.923 |
KBWP | 0.921 |
AGNCP | 0.917 |
ADTH | 0.914 |
VCEL | 0.914 |
BUFF | 0.903 |
SRPT | 0.899 |
MRUS | 0.896 |
LPLA | 0.893 |
IBKR | 0.892 |
10 Najbardziej negatywne korelacje | |
---|---|
WINT | -0.929 |
TBLT | -0.919 |
MNSB | -0.911 |
IMMX | -0.91 |
PRSO | -0.909 |
KXIN | -0.907 |
WALD | -0.907 |
GOVX | -0.906 |
RDHL | -0.906 |
LGVN | -0.905 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Tarsus Pharmaceuticals, Korelacja - Waluta/Towar
Tarsus Pharmaceuticals, Finanse
Annual | 2023 |
Przychody: | $17.45M |
Zysk brutto: | $15.85M (90.87 %) |
EPS: | $-4.62 |
FY | 2023 |
Przychody: | $17.45M |
Zysk brutto: | $15.85M (90.87 %) |
EPS: | $-4.62 |
FY | 2022 |
Przychody: | $25.82M |
Zysk brutto: | $24.86M (96.30 %) |
EPS: | $-2.52 |
FY | 2021 |
Przychody: | $57.03M |
Zysk brutto: | $57.03M (100.00 %) |
EPS: | $-0.00200 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Tarsus Pharmaceuticals,
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej